BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11812271)

  • 1. Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen.
    Shortall SP; Blum J; Oldenburg FA; Rodgerson L; Branscombe JM; Harrow EM
    Respir Care; 2002 Feb; 47(2):154-8. PubMed ID: 11812271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
    Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC;
    Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
    Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
    Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy.
    Tashkin DP; Klein GL; Colman SS; Zayed H; Schonfeld WH
    Am J Med; 2007 May; 120(5):435-41. PubMed ID: 17466655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
    Duarte AG; Momii K; Bidani A
    Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations.
    Woods JA; Usery JB; Self TH; Finch CK
    South Med J; 2011 Nov; 104(11):742-5. PubMed ID: 22024782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing.
    Deerojanawong J; Manuyakorn W; Prapphal N; Harnruthakorn C; Sritippayawan S; Samransamruajkit R
    Pediatr Pulmonol; 2005 May; 39(5):466-72. PubMed ID: 15786440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.
    Niewoehner DE; Erbland ML; Deupree RH; Collins D; Gross NJ; Light RW; Anderson P; Morgan NA
    N Engl J Med; 1999 Jun; 340(25):1941-7. PubMed ID: 10379017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
    Duffy N; Walker P; Diamantea F; Calverley PM; Davies L
    Thorax; 2005 Sep; 60(9):713-7. PubMed ID: 15939732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers.
    Chrischilles E; Gilden D; Kubisiak J; Rubenstein L; Shah H
    Am J Manag Care; 2002 Oct; 8(10):902-11. PubMed ID: 12395958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
    von Berg A; Jeena PM; Soemantri PA; Vertruyen A; Schmidt P; Gerken F; Razzouk H
    Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review and economic evaluation of bronchodilator delivery methods in hospitalized patients.
    Turner MO; Gafni A; Swan D; FitzGerald JM
    Arch Intern Med; 1996 Oct; 156(18):2113-8. PubMed ID: 8862104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.